Celprogen Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $110K

Celprogen General Information

Description

Developer of stem cell research and therapeutic products intended for regenerative medicine in cardiology, oncology, diabetes, and neurology. The company offers biological products, including stem cells and cancer stem cells for tissue and organ transplants, research tools and solutions for assays, enzymes, antibodies, and antigens, along with therapeutic product development services that support biotechnology, pharmaceutical, in vitro diagnostics, and academic partnerships focused on drug discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • 3914 Del Amo Boulevard
  • Suite 901
  • Torrance, CA 90503
  • United States
+1 (877)
Primary Industry
Biotechnology
Corporate Office
  • 3914 Del Amo Boulevard
  • Suite 901
  • Torrance, CA 90503
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celprogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 13-Jun-2023 $110K Completed Generating Revenue
To view Celprogen’s complete valuation and funding history, request access »

Celprogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of stem cell research and therapeutic products intended for regenerative medicine in cardiology, oncology, dia
Biotechnology
Torrance, CA

San Antonio, TX
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celprogen Competitors (53)

One of Celprogen’s 53 competitors is StemBioSys, a Venture Capital-Backed company based in San Antonio, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
StemBioSys Venture Capital-Backed San Antonio, TX
NOVADIP Venture Capital-Backed Mont-Saint-Guibert, Belgium
RoosterBio Venture Capital-Backed Frederick, MD
Capricor Therapeutics Formerly VC-backed San Diego, CA
Sana Biotechnology Formerly VC-backed Seattle, WA
You’re viewing 5 of 53 competitors. Get the full list »

Celprogen FAQs

  • When was Celprogen founded?

    Celprogen was founded in 2002.

  • Where is Celprogen headquartered?

    Celprogen is headquartered in Torrance, CA.

  • What industry is Celprogen in?

    Celprogen’s primary industry is Biotechnology.

  • Is Celprogen a private or public company?

    Celprogen is a Private company.

  • What is Celprogen’s current revenue?

    The current revenue for Celprogen is .

  • How much funding has Celprogen raised over time?

    Celprogen has raised $110K.

  • Who are Celprogen’s competitors?

    StemBioSys, NOVADIP, RoosterBio, Capricor Therapeutics, and Sana Biotechnology are some of the 53 competitors of Celprogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process